Daryl A. ("Sandy") Chamblee

Partner

• schamble@steptoe.com
• vCard
• Washington Office

Sandy Chamblee is a partner in the Washington office of Steptoe & Johnson LLP, where she is a member of the Litigation Department.  She has 20 years of experience as an attorney, senior advisor, and executive in policy analysis and development, conflict resolution, and strategic planning related to biotechnology, health care, and complex, multiparty litigation in the insurance and energy contexts.  Between 1992 and 1995, Ms. Chamblee briefly left law practice to serve in two senior policy positions at the National Institutes of Health, most recently as Deputy Director for Science Policy and Technology Transfer (Acting).  In addition, between April and October 1997, she chaired the Board of Directors of Columbia Hospital for Women Foundation in  Washington, DC, serving as well as a co-administrator of the hospital on many issues.

Since her return to Steptoe, Ms. Chamblee has concentrated in practice areas involving life sciences, health, or medical issues.  In the area of toxic tort litigation, Ms. Chamblee has focused on the development of the medical, epidemiological, and toxicological aspects of causation, through work with appropriate experts.  In biotechnology, Ms. Chamblee has focused on issues related to collaborative or equity arrangements or joint ventures between research entities, pharmaceutical, and/or biotechnology companies for the development, acquisition, and exploitation of biomedical assets.  These issues have concerned formulating corporate policy, negotiating and drafting sponsored research agreements, delineating and protecting intellectual property interests, and resolving related disputes.

Ms. Chamblee also has substantial experience in administrative and civil litigation, including insurance coverage, health care, and energy-related matters.

Ms. Chamblee has testified before Congress and has spoken broadly on various biotechnology issues, including collaborative research and product pricing issues, and has recently written on managed care legislation.

Select News & Events

• Steptoe Names Chamblee First Chief Diversity Partner
• Steptoe Clients Now a Family
• Product Safety Webinar—Product Recalls: Effectively Managing the Process, January 10, 2008, (A Steptoe-sponsored event)

Publications

• "Challenges to Plaintiffs' Experts in Toxic Tort Cases: De-Bunking the Junk in Medical Causation Opinions,"
  2007, Exploring Toxic Tort and Environmental Liability Claims (DRI Defense Library Series)

Professional Affiliations

• Trustee, University of Maryland Baltimore Foundation, Inc., June 2005-present
• Member, Federal City Council 1997-present; Executive Committee, 2000-04
• Member, Board of Governors, District of Columbia Bar, 1985-89; Secretary, 1985-86
• Member, Board of Directors, Columbia Hospital for Women Foundation and the Medical Center, 1987-97; Chair, Foundation Board, April 1997-October 1997; Chair, Medical Center Board's Performance Improvement Committee, 1995-96